210 related articles for article (PubMed ID: 8382422)
1. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
2. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.
Ijaz MK; Attah-Poku SK; Redmond MJ; Parker MD; Sabara MI; Frenchick P; Babiuk LA
J Virol; 1991 Jun; 65(6):3106-13. PubMed ID: 1851871
[TBL] [Abstract][Full Text] [Related]
3. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
4. Protective immunity induced by rotavirus DNA vaccines.
Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
[TBL] [Abstract][Full Text] [Related]
5. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
6. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus subunit vaccines.
Conner ME; Crawford SE; Barone C; O'Neal C; Zhou YJ; Fernandez F; Parwani A; Saif LJ; Cohen J; Estes MK
Arch Virol Suppl; 1996; 12():199-206. PubMed ID: 9015116
[TBL] [Abstract][Full Text] [Related]
8. Rotavirus virus-like particles administered mucosally induce protective immunity.
O'Neal CM; Crawford SE; Estes MK; Conner ME
J Virol; 1997 Nov; 71(11):8707-17. PubMed ID: 9343229
[TBL] [Abstract][Full Text] [Related]
9. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
10. Virus-like particles as a rotavirus subunit vaccine.
Conner ME; Zarley CD; Hu B; Parsons S; Drabinski D; Greiner S; Smith R; Jiang B; Corsaro B; Barniak V; Madore HP; Crawford S; Estes MK
J Infect Dis; 1996 Sep; 174 Suppl 1():S88-92. PubMed ID: 8752296
[TBL] [Abstract][Full Text] [Related]
11. Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge.
Mackow ER; Vo PT; Broome R; Bass D; Greenberg HB
J Virol; 1990 Apr; 64(4):1698-703. PubMed ID: 2157052
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice.
Bertolotti-Ciarlet A; Ciarlet M; Crawford SE; Conner ME; Estes MK
Vaccine; 2003 Sep; 21(25-26):3885-900. PubMed ID: 12922123
[TBL] [Abstract][Full Text] [Related]
13. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccines against rotavirus infections.
Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Robinson HL
Arch Virol Suppl; 1996; 12():207-15. PubMed ID: 9015117
[TBL] [Abstract][Full Text] [Related]
15. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice.
Dharakul T; Labbe M; Cohen J; Bellamy AR; Street JE; Mackow ER; Fiore L; Rott L; Greenberg HB
J Virol; 1991 Nov; 65(11):5928-32. PubMed ID: 1656079
[TBL] [Abstract][Full Text] [Related]
16. Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.
Herrmann JE; Chen SC; Jones DH; Tinsley-Bown A; Fynan EF; Greenberg HB; Farrar GH
Virology; 1999 Jun; 259(1):148-53. PubMed ID: 10364499
[TBL] [Abstract][Full Text] [Related]
17. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model.
Feng N; Vo PT; Chung D; Vo TV; Hoshino Y; Greenberg HB
J Infect Dis; 1997 Feb; 175(2):330-41. PubMed ID: 9203654
[TBL] [Abstract][Full Text] [Related]
18. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
19. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.
Jiang B; Estes MK; Barone C; Barniak V; O'Neal CM; Ottaiano A; Madore HP; Conner ME
Vaccine; 1999 Feb; 17(7-8):1005-13. PubMed ID: 10067709
[TBL] [Abstract][Full Text] [Related]
20. Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring.
Coste A; Cohen J; Reinhardt M; Kraehenbuhl JP; Sirard JC
Vaccine; 2001 Jul; 19(30):4167-74. PubMed ID: 11457542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
